QT
DTIL icon

Quantbot Technologies’s Precision BioSciences DTIL Stock Holding History

Quantbot Technologies’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-669
Closed -$26K – 1768
2022
Q3 		$26K Buy
669
+652
+3,835% +$31K ﹤0.01% 1331
2022
Q2 		$0 Sell
17
-370
-96% -$21.7K ﹤0.01% 1794
2022
Q1 		$35K Buy
+387
New +$52.6K ﹤0.01% 1267

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quantbot Technologies's DTIL Position: Q4 2022 in Review

Quantbot Technologies sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 669 shares — an estimated $26K sold.

Quantbot Technologies first reported a position in DTIL in Q1 2022 and held it in 3 quarters. The position peaked at $35K in Q1 2022. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Quantbot Technologies reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 669 Precision BioSciences shares in Q4 2022, an estimated $26K.
  • Quantbot Technologies first reported a position in Precision BioSciences in Q1 2022 and held it in 3 quarters.
  • Quantbot Technologies's Precision BioSciences position peaked at $35K in Q1 2022.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.